Tabernanthine Explained

Tabernanthine is an alkaloid found in Tabernanthe iboga.[1]

It has been used in laboratory experiments to study how addiction affects the brain.[2]

Tabernanthine persistently reduced the self-administration of cocaine and morphine in rats.[3]

Pharmacology

It is kappa opioid agonist (Ki = 0.15 μM) and NMDA receptor (Ki = 10.5 μM) antagonist.[4] [5] Compared to ibogaine, it binds weakly to σ1 and σ2 receptor.

See also

Notes and References

  1. The Alkaloids of Tabernanthe iboga. Part IV.1 The Structures of Ibogamine, Ibogaine, Tabernanthine and Voacangine . Journal of the American Chemical Society. 80. 126–136. 10.1021/ja01534a036 . 1958. Bartlett MF, Dickel DF, Taylor WI .
  2. Levi MS, Borne RF . A review of chemical agents in the pharmacotherapy of addiction . Current Medicinal Chemistry . 9 . 20 . 1807–1818 . October 2002 . 12369879 . 10.2174/0929867023368980 .
  3. Glick SD, Kuehne ME, Raucci J, Wilson TE, Larson D, Keller RW, Carlson JN . Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum . Brain Research . 657 . 1–2 . 14–22 . September 1994 . 7820611 . 10.1016/0006-8993(94)90948-2 . 1940631 .
  4. Deecher DC, Teitler M, Soderlund DM, Bornmann WG, Kuehne ME, Glick SD . Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies . Brain Research . 571 . 2 . 242–247 . February 1992 . 1377086 . 10.1016/0006-8993(92)90661-r . 17159661 .
  5. Book: Wiart C . Lead Compounds from Medicinal Plants for the Treatment of Neurodegenerative Diseases. 16 December 2013. Academic Press. 978-0-12-398383-1. 67–69, 73.